《港樓》恆地(00012.HK)土瓜灣新盤命名「壹沐」 分兩期發展共提供812伙
恆地(00012.HK)位於土瓜灣的新盤正式命名為「壹沐HIGHWOOD」,提供812伙,分別以兩期推出,第1期將提供401個單位。戶型涵蓋一房至三房及少量特色單位,當中主打一房及兩房戶型。項目第一期的預計關鍵日期為2027年5月31日。
恆基物業代理有限公司董事及營業(一)部總經理林達民表示,項目部署9月正式推售第一期,有機會同月賣樓。另外 ,第二期提供411伙,有機會於今年內推售。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.